NEW YORK, Oct. 25, 2022 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation into potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ:ESTA) arising from allegations that the company may be disclosing materially misleading business information to the investing public Has .

SO WHAT: If you have purchased Establishment Labs securities, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement. Law firm Rosen is preparing a class action lawsuit to recover investor losses.

WHAT TO DO NEXT: To participate in the prospective class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=9304 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for information about the Class Action.

WHAT IS THIS ABOUT: On October 19, 2022, market analyst Hindenburg Research published a report titled “Establishment Labs: A Financially Stretched Silicone Safety Charade,” which claimed, among other things, that “[d]Despite claims of superior safety, we have found that almost all of the major safety studies touted by the company have conflicts of interest, many of which are under-disclosed or under-disclosed.” The report goes on to say that “the company claims successful to have tested a ‘revolutionary’ technique for placing implants through the armpit under local anesthesia (instead of general anesthesia) and claims the technique will significantly expand its Total Addressable Market (TAM). This type of insertion has been described since the 1970s and has been widespread for almost 20 years. It has not caught on due to security risks.”

The report also claimed that “[b]In addition to undisclosed security issues, we have also identified financial risks. Import/Export records show that the company supplies products to companies formerly owned by the CEO and his family, raising questions about conflicts…